• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β2 - 肾上腺素能受体与多发性硬化症中的炎性脱髓鞘和轴突退变的关系

Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.

作者信息

De Keyser Jacques, Zeinstra Esther, Mostert Jop, Wilczak Nadine

机构信息

Department of Neurology, University Hospital Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.

出版信息

Trends Pharmacol Sci. 2004 Feb;25(2):67-71. doi: 10.1016/j.tips.2003.12.002.

DOI:10.1016/j.tips.2003.12.002
PMID:15102491
Abstract

Relapses of multiple sclerosis (MS) are considered to be the clinical expression of acute T-cell-mediated inflammatory demyelinating lesions disseminated in the CNS, whereas disease progression seems to result from widespread axonal degeneration. The pathophysiology of both disease components is incompletely understood. Astrocytes in MS lack beta(2)-adrenoceptors, which via cAMP-mediated processes inhibit the expression of major histocompatibility (MHC) class II molecules and stimulate glycogenolysis in normal conditions. In a pro-inflammatory CNS environment this beta(2)-adrenoceptor defect might allow astrocytes to transform into facultative antigen-presenting cells that can initiate the inflammatory cascade. The same receptor defect might impair astrocytic glycogenolysis, which normally generates lactate that is transported to axons as an energy source. Failure of axonal energy metabolism might result in axonal degeneration through mechanisms that involve intra-axonal accumulation of Ca(2+) ions and mitochondrial dysfunction. If this hypothesis is correct, therapies designed to elevate cAMP levels in astrocytes should reduce or prevent both relapses and progression of MS.

摘要

多发性硬化症(MS)的复发被认为是中枢神经系统中急性T细胞介导的炎症性脱髓鞘病变的临床表现,而疾病进展似乎是由广泛的轴突变性引起的。这两种疾病成分的病理生理学尚未完全了解。MS中的星形胶质细胞缺乏β(2)-肾上腺素能受体,在正常情况下,该受体通过cAMP介导的过程抑制主要组织相容性(MHC)II类分子的表达并刺激糖原分解。在促炎性中枢神经系统环境中,这种β(2)-肾上腺素能受体缺陷可能使星形胶质细胞转变为兼性抗原呈递细胞,从而引发炎症级联反应。相同的受体缺陷可能会损害星形胶质细胞的糖原分解,而糖原分解通常会产生乳酸,并作为能量来源转运至轴突。轴突能量代谢的失败可能通过涉及轴突内Ca(2+)离子积累和线粒体功能障碍的机制导致轴突变性。如果这一假设正确,那么旨在提高星形胶质细胞中cAMP水平的疗法应能减少或预防MS的复发和进展。

相似文献

1
Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.β2 - 肾上腺素能受体与多发性硬化症中的炎性脱髓鞘和轴突退变的关系
Trends Pharmacol Sci. 2004 Feb;25(2):67-71. doi: 10.1016/j.tips.2003.12.002.
2
Astrocytic beta2-adrenergic receptors and multiple sclerosis.星形胶质细胞β2 - 肾上腺素能受体与多发性硬化症
Neurobiol Dis. 2004 Mar;15(2):331-9. doi: 10.1016/j.nbd.2003.10.012.
3
The pathology of multiple sclerosis and its evolution.多发性硬化症的病理学及其演变。
Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1635-40. doi: 10.1098/rstb.1999.0508.
4
Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis.星形胶质细胞作为抑制多发性硬化症炎症性脱髓鞘病变的潜在靶点。
Neurochem Int. 2010 Nov;57(4):446-50. doi: 10.1016/j.neuint.2010.02.012. Epub 2010 Feb 21.
5
Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice.轴突退变是小鼠自身免疫介导的脱髓鞘病变的早期病理特征。
Microsc Res Tech. 2001 Mar 15;52(6):731-9. doi: 10.1002/jemt.1057.
6
Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.实验性自身免疫性脑脊髓炎发病前期与星形胶质细胞相关的轴突损伤
Glia. 2005 Aug 15;51(3):235-40. doi: 10.1002/glia.20199.
7
[Neuronal injury in multiple sclerosis].[多发性硬化症中的神经元损伤]
Medicina (B Aires). 2006;66(5):472-85.
8
Macrophages and neurodegeneration.巨噬细胞与神经退行性变
Brain Res Brain Res Rev. 2005 Apr;48(2):185-95. doi: 10.1016/j.brainresrev.2004.12.008.
9
Sodium channels as molecular targets in multiple sclerosis.钠通道作为多发性硬化症的分子靶点。
J Rehabil Res Dev. 2002 Mar-Apr;39(2):233-42.
10
Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis.线粒体功能障碍在多发性硬化症的进行性轴突丧失中起关键作用。
Med Hypotheses. 2005;64(4):669-77. doi: 10.1016/j.mehy.2004.09.001.

引用本文的文献

1
From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease.从血脑屏障到神经血管单元:健康与疾病状态下少突胶质细胞的生物能量需求及挑战
J Neurochem. 2025 Jan;169(1):e16219. doi: 10.1111/jnc.16219. Epub 2024 Sep 10.
2
Noradrenergic Hypothesis Linking Neurodegeneration-Based Cognitive Decline and Astroglia.将基于神经退行性变的认知衰退与星形胶质细胞联系起来的去甲肾上腺素能假说。
Front Mol Neurosci. 2018 Jul 27;11:254. doi: 10.3389/fnmol.2018.00254. eCollection 2018.
3
Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion.
星形胶质细胞作为中枢神经系统的分泌细胞:囊泡分泌的特性
EMBO J. 2016 Feb 1;35(3):239-57. doi: 10.15252/embj.201592705. Epub 2016 Jan 12.
4
The effect of fluoxetine on progression in progressive multiple sclerosis: a double-blind, randomized, placebo-controlled trial.氟西汀对进展型多发性硬化症病情进展的影响:一项双盲、随机、安慰剂对照试验。
ISRN Neurol. 2013 Jul 29;2013:370943. doi: 10.1155/2013/370943. eCollection 2013.
5
Astrocytic vesicle mobility in health and disease.健康与疾病状态下星形胶质细胞囊泡的移动性
Int J Mol Sci. 2013 May 27;14(6):11238-58. doi: 10.3390/ijms140611238.
6
G protein-coupled receptors as therapeutic targets for multiple sclerosis.G 蛋白偶联受体作为多发性硬化症的治疗靶点。
Cell Res. 2012 Jul;22(7):1108-28. doi: 10.1038/cr.2012.87. Epub 2012 Jun 5.
7
Neuroimmune interaction in inflammatory diseases.炎症性疾病中的神经免疫相互作用。
Clin Med Circ Respirat Pulm Med. 2008 Apr 29;2:35-44. doi: 10.4137/ccrpm.s547.
8
IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism.胰岛素样生长因子-1通过β2-肾上腺素能受体依赖性机制调节星形胶质细胞中的环磷酸腺苷水平。
Int J Med Sci. 2008 Aug 6;5(5):240-3. doi: 10.7150/ijms.5.240.
9
Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.不同病程多发性硬化症患者血清和外周血白细胞中的氧化应激
J Neurol. 2006 Apr;253(4):483-7. doi: 10.1007/s00415-005-0037-3. Epub 2005 Nov 14.
10
What do we know about the mechanism of action of disease-modifying treatments in MS?我们对多发性硬化症中疾病修饰治疗的作用机制了解多少?
J Neurol. 2004 Sep;251 Suppl 5:v12-v29. doi: 10.1007/s00415-004-1504-y.